Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5698929 | Clinical Oncology | 2011 | 7 Pages |
Abstract
Sequential or simultaneous integrated boost to the SCF was safe and feasible. This is the first publication of dose escalation to the SCF when treating breast cancer with brachial plexus-sparing IMRT techniques. The feasibility of such techniques warrants a multicentre phase II study of dose escalation with IMRT to improve local control in isolated SCF disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Chatterjee, D. Lee, N. Kent, T. Wintle, J.H. Mott, C.G. Kelly, A.N. Branson,